TY  - JOUR
A1  - Schmid, Richard
A1  - Tarau, Ioana-Sandra
A1  - Rossi, Angela
A1  - Leonhardt, Stefan
A1  - Schwarz, Thomas
A1  - Schuerlein, Sebastian
A1  - Lotz, Christian
A1  - Hansmann, Jan
T1  - In Vivo-Like Culture Conditions in a Bioreactor Facilitate Improved Tissue Quality in Corneal Storage
JF  - Biotechnology Journal
N2  - The cornea is the most-transplanted tissue worldwide. However, the availability and quality of grafts are limited due to the current methods of corneal storage. In this study, a dynamic bioreactor system is employed to enable the control of intraocular pressure and the culture at the air-liquid interface. Thereby, in vivo-like storage conditions are achieved. Different media combinations for endothelium and epithelium are tested in standard and dynamic conditions to enhance the viability of the tissue. In contrast to culture conditions used in eye banks, the combination of the bioreactor and biochrom medium 1 allows to preserve the corneal endothelium and the epithelium. Assessment of transparency, swelling, and the trans-epithelial-electrical-resistance (TEER) strengthens the impact of the in vivo-like tissue culture. For example, compared to corneas stored under static conditions, significantly lower optical densities and significantly higher TEER values were measured (p-value <0.05). Furthermore, healing of epithelial defects is enabled in the bioreactor, characterized by re-epithelialization and initiated stromal regeneration. Based on the obtained results, an easy-to-use 3D-printed bioreactor composed of only two parts was derived to translate the technology from the laboratory to the eye banks. This optimized bioreactor facilitates noninvasive microscopic monitoring. The improved storage conditions ameliorate the quality of corneal grafts and the storage time in the eye banks to increase availability and reduce re-grafting.
KW  - bioreactor
KW  - corneal endothelium
KW  - corneal epithelium
KW  - corneal storage
KW  - tissue culture
Y1  - 2018
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-228620
VL  - 13
IS  - 1,1700344
ER  - 
TY  - JOUR
A1  - Kämmerer, Peer W.
A1  - Tribius, Silke
A1  - Cohrs, Lena
A1  - Engler, Gabriel
A1  - Ettl, Tobias
A1  - Freier, Kolja
A1  - Frerich, Bernhard
A1  - Ghanaati, Shahram
A1  - Gosau, Martin
A1  - Haim, Dominik
A1  - Hartmann, Stefan
A1  - Heiland, Max
A1  - Herbst, Manuel
A1  - Hoefert, Sebastian
A1  - Hoffmann, Jürgen
A1  - Hölzle, Frank
A1  - Howaldt, Hans-Peter
A1  - Kreutzer, Kilian
A1  - Leonhardt, Henry
A1  - Lutz, Rainer
A1  - Moergel, Maximilian
A1  - Modabber, Ali
A1  - Neff, Andreas
A1  - Pietzka, Sebastian
A1  - Rau, Andrea
A1  - Reichert, Torsten E.
A1  - Smeets, Ralf
A1  - Sproll, Christoph
A1  - Steller, Daniel
A1  - Wiltfang, Jörg
A1  - Wolff, Klaus-Dietrich
A1  - Kronfeld, Kai
A1  - Al-Nawas, Bilal
T1  - Adjuvant radiotherapy in patients with squamous cell carcinoma of the oral cavity or oropharynx and solitary ipsilateral lymph node metastasis (pN1) — a prospective multicentric cohort study
JF  - Cancers
N2  - (1) Background: Evaluation of impact of adjuvant radiation therapy (RT) in patients with oral squamous cell carcinoma of the oral cavity/oropharynx (OSCC) of up to 4 cm (pT1/pT2) and solitary ipsilateral lymph node metastasis (pN1). A non-irradiated group with clinical follow-up was chosen for control, and survival and quality of life (QL) were compared; (2) Methods: This prospective multicentric comprehensive cohort study included patients with resected OSCC (pT1/pT2, pN1, and cM0) who were allocated into adjuvant radiation therapy (RT) or observation. The primary endpoint was overall survival. Secondary endpoints were progression-free survival and QL after surgery; (3) Results: Out of 27 centers, 209 patients were enrolled with a median follow-up of 3.4 years. An amount of 137 patients were in the observation arm, and 72 received adjuvant irradiation. Overall survival did not differ between groups (hazard ratio (HR) 0.98 [0.55–1.73], p = 0.94). There were fewer neck metastases (HR 0.34 [0.15–0.77]; p = 0.01), as well as fewer local recurrences (HR 0.41 [0.19–0.89]; p = 0.02) under adjuvant RT. For QL, irradiated patients showed higher values for the symptom scale pain after 0.5, two, and three years (all p < 0.05). After six months and three years, irradiated patients reported higher symptom burdens (impaired swallowing, speech, as well as teeth-related problems (all p < 0.05)). Patients in the RT group had significantly more problems with mouth opening after six months, one, and two years (p < 0.05); (4) Conclusions: Adjuvant RT in patients with early SCC of the oral cavity and oropharynx does not seem to influence overall survival, but it positively affects progression-free survival. However, irradiated patients report a significantly decreased QL up to three years after therapy compared to the observation group.
KW  - oral squamous cell carcinoma
KW  - oropharyngeal carcinoma
KW  - surgery
KW  - resection
KW  - radiotherapy
KW  - survival
KW  - progression-free survival
KW  - quality of life
KW  - prospective
KW  - multicentric
KW  - lymph node
KW  - pN1
Y1  - 2023
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-311024
SN  - 2072-6694
VL  - 15
IS  - 6
ER  -